These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27408611)

  • 1. Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries.
    McMahon JH; Spelman T; Ford N; Greig J; Mesic A; Ssonko C; Casas EC; O'Brien DP
    AIDS Res Ther; 2016; 13():25. PubMed ID: 27408611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD.
    Jiamsakul A; Kerr SJ; Ng OT; Lee MP; Chaiwarith R; Yunihastuti E; Van Nguyen K; Pham TT; Kiertiburanakul S; Ditangco R; Saphonn V; Sim BL; Merati TP; Wong W; Kantipong P; Zhang F; Choi JY; Pujari S; Kamarulzaman A; Oka S; Mustafa M; Ratanasuwan W; Petersen B; Law M; Kumarasamy N;
    Trop Med Int Health; 2016 May; 21(5):662-74. PubMed ID: 26950901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.
    Pujades-Rodríguez M; Balkan S; Arnould L; Brinkhof MA; Calmy A;
    JAMA; 2010 Jul; 304(3):303-12. PubMed ID: 20639564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Same-day antiretroviral therapy is associated with increased loss to follow-up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV.
    Joseph Davey D; Kehoe K; Serrao C; Prins M; Mkhize N; Hlophe K; Sejake S; Malone T
    J Int AIDS Soc; 2020 Jun; 23(6):e25529. PubMed ID: 32510186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-ART nutritional status and its association with mortality in adult patients enrolled on ART at Fiche Hospital in North Shoa, Oromia region, Ethiopia: a retrospective cohort study.
    Tesfamariam K; Baraki N; Kedir H
    BMC Res Notes; 2016 Dec; 9(1):512. PubMed ID: 27998310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15.
    Gesesew HA; Ward P; Woldemichael K; Mwanri L
    PLoS One; 2018; 13(6):e0198815. PubMed ID: 29912974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.
    Nimkar S; Valvi C; Kadam D; Rewari BB; Kinikar A; Gupte N; Suryavanshi N; Deluca A; Shankar A; Golub J; Bollinger R; Gupta A; Marbaniang I; Mave V
    HIV Med; 2018 Jul; 19(6):395-402. PubMed ID: 29573312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.
    Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R
    BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern Ethiopia.
    Haile D; Takele A; Gashaw K; Demelash H; Nigatu D
    PLoS One; 2016; 11(10):e0164299. PubMed ID: 27716827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
    McGrath N; Lessells RJ; Newell ML
    HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique.
    Molfino L; Kumar AM; Isaakidis P; Van den Bergh R; Khogali M; Hinderaker SG; Magaia A; Lobo S; Edwards CG; Walter J
    Glob Health Action; 2014; 7():23758. PubMed ID: 24717189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.
    Tweve EN; Kayabu D; Nassari NO; Todd J
    Trop Med Int Health; 2015 Jun; 20(6):791-6. PubMed ID: 25706518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.
    Stringer JS; Zulu I; Levy J; Stringer EM; Mwango A; Chi BH; Mtonga V; Reid S; Cantrell RA; Bulterys M; Saag MS; Marlink RG; Mwinga A; Ellerbrock TV; Sinkala M
    JAMA; 2006 Aug; 296(7):782-93. PubMed ID: 16905784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival in HIV treatment programmes in Asia.
    De La Mata NL; Kumarasamy N; Khol V; Ng OT; Van Nguyen K; Merati TP; Pham TT; Lee MP; Durier N; Law M
    Antivir Ther; 2016; 21(6):517-527. PubMed ID: 26961354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.